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Abstract. Rare lung diseases affect 1.5-3 million people in Europe while causing 
bad prognosis or early deaths for patients. The European Reference Network for 
Respiratory Diseases (ERN-Lung) is a patient centric network, funded by the 
European Union (EU). The aims of ERN-LUNG is to increase healthcare and 
research regarding rare respiratory diseases. An initial need for cross-border 
healthcare and research is the use of registries and databases. A typical problem in 
registries for RDs is the data exchange, since the registries use different kind of data 
with different types or descriptions. Therefore, ERN-Lung decided to create a new 
Registry Data-Warehouse (RDW) where different existing registries are connected 
to enable cross-border healthcare within ERN-Lung. This work facilitates the aims, 
conception and implementation for the RDW, while considering a semantic 
interoperability approach. We created a common dataset (CDS) to have a common 
descriptions of respiratory diseases patients within the ERN registries. We further 
developed the RDW based on Open Source Registry System for Rare Diseases 
(OSSE), which includes a Metadata Repository with the Samply.MDR to unique 
describe data for the minimal dataset. Within the RDW, data from existing registries 
is not stored in a central database. The RDW uses the approach of the “Decentral 
Search” and can send requests to the connected registries, whereas only aggregated 
data is returned about how many patients with specific characteristics are available. 
However, further work is needed to connect the different existing registries to the 
RDW and to perform first studies.   
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1. Introduction 
Rare lung diseases affect about 1.5 up to 3 million people in Europe. Some of these 
diseases belong to mucociliary clearance (MCC) disorders [1]. Such diseases are Cystic 
Fibrosis (CF), Primary Ciliary Dyskinesia (PCD) and non-CF bronchiectasis (non-CF 
BE). These complex lung diseases require multidisciplinary care due to the complexity, 
as these diseases can affect multiple organ systems. Furthermore, other rare lung diseases 
like Pulmonary Arterial Hypertension (PAH) are causing bad prognosis for patients [2]. 
Thus, early diagnosis and access to specialists in this field are necessary in order to 
improve outcomes [3].  
The European Reference Network for Respiratory diseases (ERN-Lung) is a patient-
centric network of healthcare providers and patient organisations. ERN-Lung is one of 
24 European Reference Networks, funded by the European Union (EU). These ERNs 
include 23 rare or low prevalence complex diseases, conditions and disease-groups, 
including more than 300 hospitals [4]. ERN-Lung currently includes 60 healthcare 
providers in 12 different countries, addressing rare respiratory diseases [3]. ERN-Lung 
is divided in core networks, which include for instance research and clinical trials, 
registries and biobanks, cross-border care and continued medical education [3]. However, 
to support clinical research for RDs, patient’s registries and databases are needed. The 
small number of patients affected by RDs make registries even more important than in 
the normal population or in common diseases as they enable cross-border gathering of 
data to achieve sufficient sample size for any purpose in clinical research and or public 
health issues [5,6]. A typical problem in registries for RDs is the data exchange [7]. Due 
to the disease specific and heterogeneity of data, registries do not provide any semantic 
interoperability to exchange data [5,8]. A system is considered as semantic interoperable 
if systems can exchange data with an unambiguous, shared meaning [9]. 
To enable data exchange as the basis for clinical research in ERN-Lung, the 
consortia have developed a new Registry Data-Warehouse (RDW) to enable cross-border 
healthcare through using semantic interoperability, while considering common standards, 
ethical and data protection regulations. The objectives of this work are to present the 
aims, a conception and software-implementation of the RDW, as well as an 
interoperability approach between existing ERN-Lung registries. For reporting our work, 
we follow the ISCIL Schema (Introduction – State of the art – Concept – Implementation 
– Lessons learned). 
Aims of the Registry Data Warehouse  
The aims of the RDW are to allow data exchange as the basis for clinical research in 
ERN-Lung. Existing and new registries will be brought together in a comprehensive 
registry landscape with interoperability across possible facets. The RDW provides 
appropriate software systems and components to achieve these goals. Clinical care 
registries will be able to exchange data with epidemiologic data registries as well as with 
healthcare utilization or health economic data registries.  
To enable the RDW in ERN-Lung, we conducted a conception and implementation 
phase. In both stages, we considered needs and ideas from all registries stakeholders, like 
clinicians and technical experts. In the conception phase, we involved all stakeholders in 
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the development of a common dataset (CDS). This record is stored in all registries and 
in the RDW and thus enables a uniform description of the patients. The data was 
described with a Metadata Repository (MDR) (shown in section 3 and 4). In the 
implementation phase, we implemented the RDW based on several software-components 
described in section 4. 
2. State of the art 
Currently, different registries in the ERN-Lung exist (shown in Table 1, which has been 
collected with a questionnaire by the registry operators). For a prototypical 
implementation of the RDW, we have chosen to create a semantic interoperability 
concept to connect the following registries: A registry for CF (European Cystic Fibrosis 
Society Patient Registry, https://www.ecfs.eu/ecfspr), PCD (International Primary 
Ciliary Dyskinesia (PCD) Registry , https://www.pcdregistry.eu), non-CF BE (European 
Bronchiectasis Registry , https://www.bronchiectasis.eu/registry) and PAH (French 
Pulmonary Hypertension Registry). As starting with these four registries, we will create 
a semantic interoperability concept, with the goal to involve all ERN-Lung registries in 
the future. 
 
Table 1. Results of the questionnaire for all visualization methods of the mockups 







2015 18000 Own 
development 
 
International Primary Ciliary 
Dyskinesia (PCD) Registry 
(PCDregistry) 
2015 1176 Own 
development  
 
European Cystic Fibrosis 
Society Patient Registry 
2008 48000 Own 
development 
 
French Pulmonary Hypertension 
Registry (FPHR)
2007 13,800 PAHTool  
3. Concept 
The RDW include the following three major elements (as shown in Figure 1): The ERN-
Lung Registry, ERN-Lung Population Registry and disease specific registries (CF, PCD, 
non-CF BE and PAH). The ERN-Lung Registry (1) will serve as an internal system for 
documentation and analysis, whereas data from other registries are connected there. The 
ERN-Lung Registry includes a CDS. The ERN-Lung Registry is governed by the ERN-
Lung Board (2). Another component is the ERN-Lung Population Registry (4) which 
offers an opportunity for patients to self-register in the registry. Between ERN-Lung 
Registry and ERN-Lung Population Registry, bidirectional semantic interoperability is 
aimed with a CDS (3). 
Most patients can only be reached by patient organizations, experts or specialized 
care centres. We want to attract as many patients affected by rare pulmonary diseases to 
get in contact with the ERN and its services. By this option we hope to get in contact 
with new patients who self-register in the ERN-Lung Population Registry for closing the 
gap of knowledge concerning the number of patients affected. This will help them to 
actively contribute to RD research and thus the ERN-Lung Population Registry can 
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contribute to patient empowerment. The ERN Patient Portal will allow patient recorded 
outcomes once the patient is registered with the system (5). The RDW will allow 
bidirectional semantic interoperability (6) between the ERN-Lung Registry, the 
Population Registry and diseases specific registries (CF, PCD, non-CF BE and PAH) (7). 
Interoperability between existing registries with a CDS is a prerequisite (8). If data is to 
be given to a third party, an anonymised copy of the relevant data is generated (9). This 
is a one-direction export functionality (10). Data sharing with the RDW (data copy export 
only) upon request might be asked for by the European Commission‘s Joint Research 
Centre (JRC) of the European Commission in Ispra, Italy (11). Furthermore, to make 
data semantically interoperable, an ERN-wide Meta Data Repository (MDR) will be 
established. A MDR is a dictionary of data-elements, describing the clinical data in a 
registry. The functionality will be increased by a Registry & Metadata Repository 
(RMDR), which stores information about which registries are connected and which are 
using which kind of data (13). To further support collaborations between researchers, a 
central ERN ID-Management System (14), described in section 4.3, will be provided to 
create unique pseudonyms in an untraceable manner based on the patients’ identifying 
data. With the help of the included ‘record linkage’ functionality, redundancies of patient 
entries can be avoided.  
 
 
Figure 1. Structure of the Registry Data-Warehouse 
Minimal dataset of ERN-Lung registries 
The ERN-Lung Registry and Population Registry will contains a set of common data 
elements for RDs as well as specific data elements customized for ERN purposes like 
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cross-border consultation. Both registries are making use of the same minimal data set 
as all other registry applications (CF, PCD, non-CF BE and PAH). The minimal dataset 
is based on the recommendation of the JRC of the European Commission. The ERN-
Lung Registry, as well as all other registries (CF, PCD, non-CF BE and PAH) will 
implement these dataset to ensure semantic interoperability between the registries. The 
datasets contains 16 elements of the JRC minimal dataset, collecting basic information 
about the patients, e.g. diagnosis, diagnosis-history and age at onset. This data is 
expanded by six further data elements for ERN-Lung administrative reasons, e.g. 
collection of information needed for cross-border consultation [10]. 
4. Implementation 
In this section, we describe the software-components that were considered for the 
implementation of the RDW. We will introduce the Open Source Registry System for 
Rare Diseases (OSSE) as a software-framework for the ERN-Lung Registry as well as 
the ERN-Lung Population Registry. Furthermore, we show the Mainzelliste as a software 
for ID- Management and the MDR to describe the medical data in the registries. 
4.1 Using OSSE for the ERN-Lung Data Warehouse 
As stated in the previous section, two registries in context of the RDW were developed. 
The ERN-Lung Registry and the ERN-Lung Population Registry. Both registries were 
developed with OSSE, which allows patient organizations, researchers and physicians to 
create patient registries based on an open-source software. OSSE is currently used in 
various international and national registries, e.g. in the  European lipodystrophy registry 
[11]. OSSE was funded by the German Federal Ministry of Health in context of the 
National Plan for Rare Diseases in 2013. In order to reach semantic interoperability 
between registries, OSSE considered at an early stage the conception of a high level of 
interoperability. An important aspect for this is provided with the metadata concept [5]. 
It is a central component of OSSE and will be described in the next section. 
There are several approaches to merge data from our local registries into the ERN-
Lung Registry. First, the data can be uploaded to a central registry or remain 
decentralized at their locations. The first approach can be critical, since data protection 
laws did not allow to duplicate or upload the data into another system. OSSE supports 
the approach of decentralised data storage. This means that the data remains in the local 
registries. OSSE provides a component called “search broker” to connect the registries 
between each other, called “decentral search”. A request, defined as a description of 
metadata can be send to one local registry, to check, if a sufficient amount of patients 
with specific characteristics are available. The request needs an approval of the data 
owner of the local registry, who will check the request. Outside the registry, a data 
exchange between both parties is possible [5]. For all registries in ERN-Lung, we aim to 
connect the registries with the decentral approach. 
4.2 Meta Data Repository & Registry & Metadata Repository (RMDR) 
Metadata is defined as data that describes the actual data concerning their structure and 
representation. This concept is used for the creation and documentation of data in OSSE 
registries and establishes the basis for data exchange between the registries. OSSE uses 
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the software module Samply.MDR (abbreviated as MDR in the following) to describe 
the data to be stored in a registry. The MDR is a software to support the specification of 
data elements in a structured, formalized and standardized way. MDR was originally 
developed in the context of the German Cancer Consortium [12]. The MDR uses the 
metadata standard ISO 11179 part 3 edition 3, which describes how metadata can be 
described [13]. As an example for data element definition, we will show the definition 
of “blood pressure” as follows. A data element called "blood pressure" is created in the 
MDR and a short description of the collected characteristic is stored. The data element 
contains two integer values: systolic blood pressure and diastolic blood pressure. It is 
stored which unit is used for the blood pressure measurement (mmHg). This is necessary, 
since different medical parameters can be described with different units (e.g. blood 
glucose with mg/dl or mmol/l). Furthermore, a validity check of each data element can 
be defined, to consider, that a value is in a certain value range or not. This means for the 
mentioned example, that a blood pressure value is never negative and therefore always 
above zero [5]. Since the MDR is connected to the OSSE-registry, electronic case report 
forms (eCRF) can be created based on the MDR. This enables the data input into the 
registry to be based on the data elements of the MDR [5]. By using the MDRs in 
combination with a CDS, semantic interoperability between all ERN-Lung registries can 
be ensured. 
As the MDR only covers metadata about data elements and not about the registries 
collecting these, our initial approach was to extend the functionality of the MDR. 
However, the European Rare Diseases Registry Infrastructure (ERDRI) has been 
developed by the JRC in February 2019. ERDRI makes rare diseases registries 
searchable and findable. Core elements of ERDRI are the Central Metadata Repository 
(ERDRI.MDR) and the European Directory of Registries (ERDRI.DOR). The 
ERDRI.MDR contains all metadata used by participating registries with their specific 
designations and definitions. With ERDRI.MDR metadata items can manually be entered 
using a graphical user interface. While establishing a new registry, a user can search for 
already existing data element specifications to select them instead of creating new data 
elements. The ERDRI.DOR gives an overview of all existing registries, including 
characteristics of these registries. In order to avoid parallel structures at European Level, 
we decided to use the ERDRI.MDR and the ERDRI.DOR for the RDW [14]. 
To use the ERDRI-Infrastructure in the RDW, adaptations to various components of 
the registry software OSSE were necessary. The OSSE Electronic Data Capture and the 
Collaboration Client, which is part of the search broker, were adapted connect to the 
ERDRI-Infrastructure.  
4.3 ID-Management 
Whenever patient data are being used for research, identity management is of crucial 
importance for reasons of data protection. Identity Management has to separate the 
identifying data (I-DAT) of the patient from the medical data (M-DAT) and to hide these 
identifying data by means of a pseudonym or by irreversibly delink these data types by 
means of anonymization. Identity Management fulfils the central data protection 
requirement: by means of pseudonymization in combination with a trusted third party, 
an accidental or intentional misuse of the data is made significantly more difficult. By 
separated storage of the different data types, an informational separation of powers is 
being achieved. 
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A special aspect of medical registries is that often several institutions cooperate with 
their own pseudonymization schemes. Therefore, the Identity Management must also be 
able to manage various pseudonyms and to merge them if necessary. Since pseudonyms 
preserve the linkage between medical data and identity data, the data remains personal 
in the legal sense, unlike with anonymization. The storage and processing of the 
pseudonyms must therefore be covered by a corresponding declaration of informed 
consent by the patient. 
To enable pseudonymization of patients, the OSSE architecture includes the local 
ID management/pseudonymization service for each national or regional OSSE registry. 
The ID management software used in OSSE is called Mainzelliste [5,15]. The software 
Mainzelliste was released as Open Source by the Medical Center of Johannes Gutenberg 
University Mainz and is already being used in various other projects. 
5. Lessons learned (Discussion) 
The European Commission recommends to enable registries to improve research and 
healthcare in rare diseases [16]. The ERN-Lung consortia follows this recommendation 
and have developed the ERN-Lung RDW. 
In this work we have shown the aims, a conception and software-implementation of 
the RDW, as well as a semantic interoperability approach between ERN-Lung registries. 
The use of OSSE, a metadata concept and a CDS, enables semantic interoperability 
between the RDW and the local registries. By using the CDS of the JRC of the European 
Commission, as well as the connection to ERDRI, makes the RDW usable and available 
on a European level. However, other ERNs are also developing similar structures within 
their networks. Using a CDS among all ERNs brings opportunity for interoperability. 
However, a standard is needed to enable data-exchange between the ERNs and their 
registries. A possibility could be the FAIR approach. This approach makes it possible to 
make data of registries Findable, Accessible, Interoperable and Reachable for research 
and healthcare. This concept is also considered and implemented in OSSE with the MDR 
and the decentral search [17].   
However, our work is currently limited to the conception and implementation of the 
ERN-Lung RDW. We have not described further legal or data-protection aspects like 
patient consent, which are not necessary for the implementation. However, patients are 
currently recruited by the registry operators and a data protection concept based on the 
General Data Protection Regulation (GDPR) is created and discussed. However, OSSE 
is complaint with the comprehensive data protection handbook for medical research 
network of the TMF e.V., a technology and methods platform and umbrella organization 
for networked medical research [18]. 
  
J. Schaaf et al. / The Registry Data Warehouse in the European Reference Network 47
6. Conclusion 
The RDW provides a possibility to connect RDs registries with a focus on respiratory 
diseases and enables semantic interoperability between the registries to increase research 
and healthcare. Further work is needed to connect the local registries via the OSSE-
bridgehead and to consider patient consent in the RDW. Currently, patient consent is 
limited to the local registries.  We hope the RDW and their data will allow a detail portrait 
of patients with different rare respiratory diseases and enables an improvement of 
patients affected with those diseases. By applying the Population Registry within the 
RDW, we invite all physicians and researcher to participate in the registry. 
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